Epigenetic Markers in Growth Restricted Human Pregnancies: a Case-controlled Study
Epigenetic Markets in Growth Restricted Human Pregnancies: A Case- Control Study
1 other identifier
observational
40
1 country
1
Brief Summary
This study is carried out to discover if a baby with restricted growth in the womb is subject to specific fetal programming which predisposes to the metabolic syndrome(diabetes,hypertension,heart disease) in adulthood.We have elected to first study this condition in Chinese population in Singapore with the eventual plan of studying all ethnic groups. This is important for understanding the molecular basis of adult-onset disease such as diabetes, identifying children at risk of developing this disease in future and targeting specific strategies for intervention and disease prevention. Intrauterine fetal programming is effected through epigenetic changes similar to those previously identified in animal studies. The epigenetic markers can be found in growth restricted Chinese pregnancies in the local population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Apr 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
August 1, 2007
CompletedFirst Posted
Study publicly available on registry
August 2, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2009
CompletedSeptember 21, 2009
September 1, 2009
August 1, 2007
September 18, 2009
Conditions
Study Arms (2)
growth-restricted Chinese pregnancies
appropriately-grown Chinese pregnancies
Eligibility Criteria
Babies from Chinese women with single pregnancies
You may qualify if:
- Chinese women,
- Singleton pregnancies,
- fetal growth restriction diagnosed clinically and by ultrasound parameters,
- Normally grown fetuses by clinical and ultrasound criteria
You may not qualify if:
- Non-Chinese women
- Multiple pregnancies
- Co-existing antenatal complications including sever pre-eclampsia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National University Hospital
Singapore, 119074, Singapore
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yap Seng Chong, MBBS
National University Hospital, Singapore
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 1, 2007
First Posted
August 2, 2007
Study Start
April 1, 2007
Study Completion
April 1, 2009
Last Updated
September 21, 2009
Record last verified: 2009-09